MicroPort Scientific (MicroPort Scientific) Other Income (Minority Interest) : $171.5 Mil (TTM As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is MicroPort Scientific Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. MicroPort Scientific's Other Income (Minority Interest) for the six months ended in Dec. 2023 was $114.2 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Dec. 2023 was $171.5 Mil.

MicroPort Scientific Other Income (Minority Interest) Historical Data

The historical data trend for MicroPort Scientific's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort Scientific Other Income (Minority Interest) Chart

MicroPort Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Minority Interest)

Get a 7-Day Free Trial

17.27

32.10

74.81

151.60

171.53

MicroPort Scientific Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Income (Minority Interest)	Get a 7-Day Free Trial															50.40	55.15	96.46	57.30	114.23

MicroPort Scientific Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $171.5 Mil.

MicroPort Scientific (OTCPK:MCRPF) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

MicroPort Scientific (MicroPort Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort Scientific Corp (OTCPK:MCRPF) » Definitions » Other Income (Minority Interest)

Comparable Companies

Traded in Other Exchanges

00853:Hong Kong MSK:Germany

Address

1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203

Website

https://www.microport.com

MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacture, R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacture, R&D of orthopedics devices. CRM business: sales, manufacture, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacture, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacture, R&D of neurovascular devices. Heart valve business: sales, manufacture, R&D of heart valve devices. Surgical robot business: sales, manufacture, R&D of surgical robot devices. Surgical devices business: sales, manufacture, R&D of surgical devices. The key revenue is from The PRC.

MicroPort Scientific (MicroPort Scientific) Headlines

From GuruFocus

Firehawk® Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet

By PRNewswire PRNewswire • 09-04-2018

MicroPort Orthopedics and Medacta Agree to Settlement on Patent Claims

By PRNewswire PRNewswire • 07-14-2021